Cheapest multiple in 16 years, or the correct price for a 1% grower.

• Bull read. Trailing P/E of 13.3× and EV/EBIT of 9.8× sit more than one standard deviation below the 16-year mean of 20.0×. Adjusted EBIT margin has already rebuilt 440 bps from the 2022 trough to 14.8% — the earnings are not trough, the multiple is.
• Bear read. Management quietly retired its 3–4% organic growth ambition set in January 2022, cut FY25 guidance mid-year, and still missed at 0.9%. Reckitt trades at a similar 10× on similar dynamics; Henkel may simply be pricing what management is doing.
• Resolution date. The H1 2026 print on 6 August is where the disagreement settles — a reaffirmed FY26 guide with Consumer Brands organic flat-or-better makes the re-rating read correct; an August cut that repeats the FY25 playbook confirms the bear.

Margin reset is real; the cash profile is tightening.

The 2022–2025 margin recovery did what management said it would: pricing caught up to raw-material inflation, the Consumer Brands merger banked €540M of savings a year early, and gross margin touched a record 50.6%. What is tightening is cash: FY25 FCF of €1.84B funded €850M of dividends plus €856M of buybacks at 100% of FCF — then management layered a $1.4B Olaplex deal on top. For this to hold, FY26 margin has to stay inside the 14.5–16.0% guide while the organic line finally clears 1%.

Sika-grade industrial bolted to a second-tier consumer house.

Adhesive Technologies (52% of sales). 16.7% adjusted EBIT margin, 16.8% ROCE on €10.7B of FY25 revenue — above Sika's 13.3% group operating margin. The moat is qualification-based: once Loctite is specified on a Boeing component or a Henkel PSA tape is inside a Samsung phone, switching triggers re-testing the customer will not voluntarily take.

Consumer Brands (47% of sales). 14.5% adjusted EBIT margin on €9.7B, competing against P&G and Unilever at a quarter of their scale. The 2022 merger of Beauty and Laundry & Home Care is done — 40% SKU reduction, €540M savings banked — but organic growth was 0.3% in 2025, and the North America logistics rebuild (the '111 approach') is still surfacing disruption.

The conglomerate discount. HEN3 trades at 9.8× EV/EBIT versus Sika's 25.9×. A Sika multiple on the adhesives segment alone is worth more than Henkel's entire current enterprise value — meaning the market is handing you Consumer Brands for free, or refusing to believe the adhesives business is really Sika-grade.

The tape has been right for three years.

• Pinned near the low. €65.48 sits 8.2% below the 200-day SMA of €71.31 and in the 6th percentile of the 52-week range. Realized 30-day volatility is 23.7% — above the 5-year 80th percentile 'stressed' band.
• The death cross is still dominant. A death cross printed on 31 March 2025; the golden cross that followed on 15 Dec 2025 was invalidated within weeks as price broke back below both moving averages. Four of six technical dimensions score negative.
• Lagging local benchmarks by 56 points. HEN3 has underperformed the German equity benchmark by roughly 56 percentage points over three years — through the entire 2024–2025 'delivery peak' of the fundamental story. The tape disagreed with the margin recovery in real time.

Buy economics, not control — the Henkel family owns the vote.

• Zero vote on a 40.7% economic stake. The preferred shares held by the public carry a dividend and an economic interest, but no governance vote. The Henkel family share-pooling agreement controls 61.8% of ordinary (voting) shares and was extended indefinitely in 2014, first terminable in 2033.
• Clean behavioral record. No related-party transactions requiring Section 111c AktG disclosure in 2024. No material insider sales surfaced. The dividend has not been cut in 20 years. Pay is variable-heavy (~75%) with ROCE, relative TSR, and ESG inside the LTI — among the cleanest DAX-40 designs.
• The KGaA is the structural red flag. The Shareholders' Committee — not the Supervisory Board — appoints the Management Board and approves strategic transactions. Any spin-off of the adhesives business, any change of CEO, any sale of the company passes through the family pool first, not shareholders.

From 'build brands' to 'buy brands' in a single year.

• Olaplex for $1.4B (March 2026). Henkel agreed to buy the premium hair-care brand at roughly 90% below its 2021 IPO valuation and a 50%+ premium to the trading price. It is the loudest signal yet that Consumer Brands growth is now an M&A problem, not an organic one.
• Record buyback cadence. The March 2025 authorization closed in March 2026 at €993M — essentially the full €1B — alongside a 10% dividend hike to €2.04 after a four-year freeze. Outside the 2022 one-off €803M program, this is the largest repurchase in company history.
• Adhesives bolt-ons piled up. Four acquisitions in 2025 added roughly €1.2B of annualized sales — including ATP Adhesive Systems signed January 2026. Management is deploying the near-net-debt-free balance sheet into the high-ROCE half of the portfolio rather than waiting for a cycle turn.